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Abstract: A new technique is presented for the non-invasive imaging of the 
dynamic response of the cornea to an air puff inducing a deformation. A 
spectral OCT instrument combined with an air tonometer in a non-collinear 
configuration was used to image the corneal deformation over full corneal 
cross-sections, as well as to obtain high speed measurements of the temporal 
evolution of the corneal apex. The entire deformation process can be 
dynamically visualized. A quantitative analysis allows direct extraction of 
several deformation parameters, such as amplitude, diameter and volume of 
the maximum deformation, as well as duration and speed of the increasing 
deformation period and the recovery period. The potential of the technique 
is demonstrated on porcine corneas in vitro under constant IOP for several 
conditions (untreated, after riboflavin instillation and under cross-linking 
with ultraviolet light), as well as on human corneas in vivo. The new 
technique has proved very sensitive to detect differences in the deformation 
parameters across conditions. We have confirmed non-invasively that 
Riboflavin and UV-cross-linking induce changes in the corneal 
biomechanical properties. Those differences appear to be the result of 
changes in constituent properties of the cornea, and not a consequence of 
changes in corneal thickness, geometry or IOP. These measurements are a 
first step for the estimation of the biomechanical properties  of corneal 
tissue, at an individual level and in vivo, to improve diagnosis and prognosis 
of diseases and treatments involving changes in the biomechanical 
properties of the cornea. 
© 2012 Optical Society of America 
OCIS codes:  (330.5370) Physiological optics; (330.4460) Ophthalmic optics and devices; 
(170.4470) Ophthalmology; (170.4500) Optical coherence tomography; (170.3880) Medical and 
biological imaging. 
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1. Introduction 
The mechanical properties of the cornea and its constituent materials are essential to relate its 
geometrical (and therefore optical) properties with its mechanical behavior [1,2]. Several 
corneal diseases, such as keratoconus [3], which lead to corneal deformation and thinning, 
affect dramatically the mechanical behavior of the cornea, and several treatments for these 
diseases attempt at modulating its biomechanical response. For example, an emerging 
treatment for keratoconus is the UV-Riboflavin cross-linking procedure, which aims at 
stiffening the weakened keratoconic corneas by creating intra and extrafibrillar bonds in the 
stromal collagen [4–6]. Other treatments such as implantation of intra-stromal rings aim at 
creating a supporting structure of the cornea, producing a flattening and a symmetrization of 
the anterior corneal surface [7]. This treatment may be highly dependent on the biomechanical 
properties of the cornea. 
Other corneal treatments largely rely on the biomechanical corneal response to produce 
(more or less permanent) refractive or corneal shape changes. For example, overnight 
orthokeratology uses reversed geometry contact lenses to reshape the cornea to correct low 
amounts of refractive errors [8]. Incisional refractive surgery [9], now of limited use because 
of its low predictability, relied completely on the biomechanical properties of the cornea. 
Corneal biomechanics is claimed to play a role (in combination with the ablation algorithm 
and laser-corneal tissue interactions) in the achieved corneal shape following laser refractive 
surgery, and particularly the corneal ectasia (corneal protrusion) developed post-LASIK by 
some patients [10–12]. Emergent corneal procedures for presbyopia (i.e. femtosecond Intracor 
treatment [13,14]) aiming at producing a change in corneal curvature in the central cornea, 
while maintaining its integrity, rely entirely on the biomechanical properties of the treated 
corneas. 
Despite the great need for the understanding and availability of corneal biomechanical 
parameters at the individual level, most of the data available today come from in vitro 
measurements of corneal biomechanics [14–21]. In vitro measurements have proved to be 
largely dependent on the technique used (with orders of magnitude differences in the reported 
corneal Young modulus of elasticity) and the experimental conditions (time post-mortem, 
hydration conditions, storage solutions, etc.). Although large efforts have been directed to the 
development of new paradigms for the analysis of experimental inflation data, in combination 
with more sophisticated models (corneal finite element models or corneal Micro-structure 
constituent based models [16,21–23]) the practical use of corneal biomechanical models have 
been somewhat limited by the reliability of the experimental input data and their validation. 
With no doubt, the understanding of corneal biomechanical properties, and the practical 
use of corneal biomechanical models will largely benefit from in vivo measurements. Many in 
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and all methods suffer inevitably from unnatural corneal hydration states [19,23]. Also, 
customized knowledge of the biomechanical properties at the individual level would allow 
incorporation of custom data into corneal biomechanical models and, in consequence, a better 
predictability of the outcomes. Knowledge of the corneal biomechanical properties at the 
individual level would allow, for example, a better selection of LASIK surgery candidates 
(identifying potential patients at risk of corneal ectasia), customization of intrastromal ring 
segments, deeper understanding of corneal biomechanics-modulating treatments or diagnosis 
and prognosis of keratoconus. 
The most important attempt to date to provide a clinical instrument to monitor the 
biomechanical response of the cornea has been the Ocular Response Analyzer (ORA, Reichert 
Ophthalmic Instruments, Buffalo, New York, USA) [24]. This instrument, an evolution of an 
air-puff tonometer, measures the changes in the light intensity recorded on a detector that 
collects light reflected from the cornea during the applanation produced by an air-puff 
impinging the cornea. The instrument derives values of the inward and outward pressure 
obtained during the dynamic applanation, which as a result of the viscous damping of the 
cornea, produces a delayed response. This difference is referred by the manufacturer as 
corneal hysteresis, due to its (indirect) relationship with corneal properties. Reports in the 
literature raise questions  on the sensitivity of the technique to monitor changes in the 
biomechanical properties of the cornea. For example, there is conflicting evidence that the 
ORA is effective in identifying keratoconic patients [24,25] or in detecting changes with 
cross-linking [26]. In general, the Ocular Response Analyzer does not provide a direct 
measure of corneal deformation upon applanation, nor a direct measurement of standard 
biomechanical parameters that describe the mechanical behavior of a material. Other 
approaches that have been suggested include Placido-ring based topography with applanation 
produced by a cantilever [27], optical coherence elastography [28] and ultrasonic 
spectroscopy [29]. 
Very recently, new approaches have been presented that attempt to overcome the lack of 
more direct measurements of corneal deformation in vivo, although the techniques are still at 
early stages. Oculus has recently presented a new high-speed Scheimpflug camera capable of 
imaging dynamic corneal deformation upon applanation with an air-puff. The instrument has 
not been yet widely released clinically, and the few available reports remain mainly 
qualitative [30,31]. Scheimpflug imaging suffers from severe geometrical distortion and by 
optical distortions (in the posterior corneal surface) which need to be corrected before 
extracting quantitative information [32–34]. 
An alternative to anterior segment imaging in the eye to the Scheimpflug camera is optical 
coherence tomography  (OCT)  [35,36]. OCT has larger axial (and potentially lateral) 
resolution than Scheimpflug imaging, and high-speed OCT allows acquisitions of more than 
100.000 A-scans/s [37,38]. The combination of OCT technology with air-puff applanation has 
been recently published [39]. Despite the high-speed capabilities of the  OCT system 
employed, the data obtained with their collinear configuration are limited to the dynamic 
acquisition of A-scans at the corneal apex, although in principle the technique could be 
applied on a larger corneal region (of primary interest for understanding full corneal 
dynamics). 
In this work, we present a new development of spectral OCT (sOCT) technology 
combined with air-puff applanation which allows monitoring corneal deformation over full 
corneal cross-sections, besides high speed imaging of the corneal apex. We demonstrate the 
potential of the technique in vitro on porcine corneas, as well as in vivo in humans. In 
particular, we show the sensitivity of the technique to detect differences in corneal 
deformation between virgin corneas, corneas treated with Riboflavin + Dextran, and corneas 
after a UV-cross-linking procedure. These measurements are a first step for the estimation of 
corneal constituent material properties in vivo. 
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2.1. Instrument implementation 
A commercial non-contact tonometer (NT 2000, Nidek, Hiroishi, Japan) was combined with a 
custom spectral domain OCT system (previously described by Grulkowski et al. [38]) to 
provide dynamic images of the corneal deformation event during an air puff. The non-contact 
tonometer provides an air puff which is directly impacting the cornea and produces a fast (~20 
ms) deformation event, identical to that used in non-contact corneal tonometry. A tilted mirror 
is attached to the tube tip providing the air puff (see Fig. 1 for a schematic diagram of the 
setup) to allow acquisition of sOCT images. 
The implementation and use of the custom-developed high-resolution sOCT instrument is 
described in detail elsewhere [38,40]. The axial range of the instrument is 7 mm in depth, 
resulting in a theoretical pixel resolution of 3.42 µm in air. The axial resolution predicted by 
the bandwidth of the superluminescent diode laser source (centered at 840 nm; Superlum, 
Ireland) is 6.9 μm. The superluminiscent diode power was set to 1.5 mW for the in vitro 
measurements, and to 1.0 mW for the in-vivo measurements. The acquisition time of the 
camera (12-bit line-scan CMOS with 4096 pixels; spL4096-140k by Basler AG, Germany) 
was set to 15 μs to provide high speed imaging of the cornea. Two configurations of the sOCT 
instrument were used to capture the dynamic behavior of the cornea: (1) 1-D measurements at 
full temporal resolution (every 15 μs) on the corneal apex, i.e. continuous A-scan recordings 
without moving the scanner; and (2) 2-D dynamic measurements (B-scans) of the horizontal 
meridians of the cornea. The lateral range of the B-scans was 15 mm, sampled with 90 A-
scans. With this configuration, the cornea was spatially sampled every 0.17 mm, and each 
corneal point was temporally sampled every 1.35 ms. 
The tube tip of the non-contact tonometer was placed at 11-mm from the eye, similarly to 
the configuration for corneal tonometry, to ensure a standard air puff on the cornea. The air 
puff configuration was set to a similar level in all experiments (“60 Manual” according to the 
denomination of the instrument used). The corneal deformation sensors of the tonometer were 
deactivated. In this configuration each air puff is released with the highest air pressure 
provided by the instrument. The tonometer measurement button was electronically controlled 
to provide a remote measurement trigger. The air tube tip of the instrument was rebuilt to 
allow the fixation of a mirror. 









Fig. 1. Detail of the setup used in the experiments (viewed from above). A tilted mirror is fixed 
to the tube tip of a modified non-contact air tonometer, and provides an optical channel to a 
custom sOCT imaging instrument (see text for details and angles). In vivo and in vitro eyes 
were measured. A custom eye holder and an intraocular pressure control system (both in gray) 
were used in the in vitro eyes. 
The mirror has a tilt angle in the horizontal direction of 45° with respect both to the 
tonometer and the sOCT instrument, to allow both instruments to point at the corneal apex 
(see Fig. 1). The mirror has an additional tilt of 8° with respect to the vertical direction, which 
prevents the horizontal scanning beam of the sOCT from vignetting by the hole in the mirror 
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angle, produced at a precision mechanical workshop. 
As a result of this geometrical configuration, there is a small angle (~8°) between the 
sOCT measurement beam axis and the air puff direction when both point at the corneal apex. 
In the experiments, the measurement (imaging) axis was used as a reference for the alignment 
of the eyes (both human in vivo and porcine in vitro). Although the resulting slightly non-
normal incidence of the air puff could potentially reduce corneal deformation, this reference is 
preferred, since it does not induce additional distortion in the images, maintaining the 
symmetry of the deformation in the scanning direction (horizontal meridians). During the 
deformation, the air puff gets slightly decentered with respect to the corneal center defined by 
the imaging axis, but only 140 μm per axial millimeter of corneal displacement. This shift can 
be considered negligible in comparison with the much wider corneal area in which the air 
pulse applies a constant force. 
The current configuration in which the tube tip is attached to the mirror produces slight 
vibrations during the air-puff release (reduced by absorbing elements disposed in the 
instrument holder). However, we have not observed any effect of those on the measurements 
during the deformation event. 
2.2. IOP control system 
All in vitro measurements were performed under constant IOP pressure (18 ± 1 mmHg). This 
was achieved by means of an automated custom pressure control system [21]. The IOP was 
adjusted by a pumping system (NE-500, New Era Pump Systems, Inc., Wantagh, NY), and 
the pressure monitored with a pressure sensor. A needle was introduced through the optical 
nerve head, and connected the eye to the pumping system and a water column (filled with 
0.9% NaCl solution). 
2.3. Calibration and validation 
Three calibration and validation measurements were performed to detect potential artifacts in 
the images due to mirror movements or misalignments: (1) Dynamic imaging of the position 
of the mirror hole/tube tip during the air puff; (2) Measurement of a flat surface and rubber 
tonometry-probe eyes; (3) Repeated extended measurements of an in vitro eye. 
The potential effect of mirror vibrations was evaluated with measurements on rigid flat 
surfaces. Correct alignment was adjusted and validated when the images of a flat surface 
appeared un-distorted, and the deformation of the probe eye symmetrical. High measurement 
repeatability was obtained during 3 hours (every 10 min). Increased variability after 3 hours of 
measurements was attributed to changes in the hydration properties of the eyes. 
2.4. Eyes and measurements 
Measurements were obtained on one eye of a 39-year old normal subject in vivo, and on fresh 
porcine enucleated eyes (virgin and after treatment) in vitro. Both in vivo and in vitro 
measurements were performed under similar instrumental conditions. Each measurement was 
repeated 5 times. The dynamic 2-D B-scan measurement mode (along the horizontal 
meridian) provides insights on the relative alignment of the eye with the air puff and the 
measuring instrument (sOCT), and therefore it was routinely used to obtain an optimal 
alignment before the 1-D measurements at full temporal resolution on the corneal apex. 
In measurements in vivo, the subject fixated a stimulus in the sOCT instrument. The 
subject was stabilized using a chin-rest. The study was approved by Institutional Review 
Boards and followed the tenets of the Declaration of Helsinki. The subject signed a consent 
form and was aware of the nature of the study. 
In measurements in vitro a custom eye holder allowed alignment of the eye to the 
instrument as well as implementing the IOP control system. The porcine eyes were obtained 
from a local slaughterhouse. A total of 6 eyes were used in the study. All eyes were initially 
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conducted after de-epitheliazation only (1 eye), after de-epitheliazation and instillation of 
Riboflavin 0.125% + Dextran 20% solution during 30 minutes every 5 minutes (4 eyes), and 
after the full standard UV-cross-linking procedure with 3 mW/cm
2 365-nm UV-A radiation, 
as described in Ref. [21] (2 eyes). All in vitro measurements were performed between 2 and 
within 6 hours post-mortem. Between measurements the eyes were kept in a refrigerator at 
4°C in a chamber with cotton soaked in physiological saline (sodium chloride 0.9%). 
2.5. Data Analysis 
Figure 2 represents schematic views of the type of images resulting from the measurements, 
and the parameters obtained for subsequent analysis. Figure 2a shows the dynamics of the 
apex (A-scans) throughout time. Figure 2.b depicts the corneal meridians (B-scans) before and 
during the deformation. 
The image pixels where re-scaled in the vertical direction to provide absolute values of 
depth (in millimeters), and in the horizontal direction to obtain absolute values of time (Fig. 
2.a; in milliseconds) and axial position (Fig. 2.b; in millimeters). 
 
Fig. 2. Diagram of the images resulting from the measurements and the corresponding 
extracted parameters. (a) Measurements of the temporal dynamics of the apex (A-scans) and 
(b) Measurements of the dynamics (B-scans) of a corneal meridian. 1: Corneal thickness. 2: 
Mean deformation speed during the increasing deformation period. 3: Peak speed (maximum 
slope) of the increasing deformation period. 4: Deformation amplitude (peak deformation, 
dividing the periods of increasing and decreasing deformation). 5: Peak speed of the decreasing 
deformation period. 6: Mean speed of the decreasing deformation period. 7: Duration of the 
increasing deformation period. 8: Duration of the decreasing deformation period. 9: overall 
duration of the deformation event. 10: Diameter of the deformed zone. 11: Displaced volume. 
12: Non-deformed corneal radius. 13: Deformed corneal radius. See text for details. 
Custom routines were developed to extract quantitative parameters from the captured set 
of images. The analysis is based on a direct comparison between the stable non-deformed 
cornea immediately before the deformation event, and the corneal deformation during the air 
puff. The corneal thickness (1, red) is obtained as the axial distance between the anterior and 
posterior surface of the cornea, evaluated at the corneal apex before the deformation, during 
maximum deformation, and immediately after the deformation. The deformation amplitude (4, 
red) at the corneal apex represents the maximum deformation depth. This instant of maximum 
deformation (corresponding to the moment when the deformation stops increasing and starts 
decreasing, i.e., when the cornea starts recovering) divides the overall deformation (9) event 
in two intervals: the increasing deformation period (7) and the decreasing deformation period 
(8). The mean increasing and decreasing deformation speeds (2 and 6, black) are obtained as 
the deformation amplitude divided by the duration of the corresponding increasing or 
decreasing deformation period (slopes of the black lines in Fig. 2a). The peak deformation 
speeds (3 and 5, orange) are also obtained for the increasing and decreasing deformation 
periods (as the maximum positive and negative slopes of the deformation curve, represented 
as orange lines in Fig. 2a). 
The parameters above were obtained from high-speed A-scan measurements at the corneal 
apex throughout (Fig. 2a). Additional information could be extracted from the dynamic B-
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direct view of the spatial deformation of the cornea. Although this corneal meridian 
measurement mode could potentially provide similar results about the apex dynamics than the 
A-scan measurements, the temporal sampling achievable is much lower and therefore the 
extracted parameters have lower precision. The B-scans were used to obtain the diameter of 
the deformed zone  (10, green), the displaced corneal volume  at the moment of peak 




Figure 3 shows three examples of dynamic A-scan measurements at the corneal apex on the 
same in vitro porcine eye before (Fig. 3a) and after treatments with Riboflavin (Fig. 3b) and 
UV-cross-linking (Fig. 3c). 
 
Fig. 3. Examples of dynamic A-scan measurements on the same porcine eye in vitro, (a) before 
and (b) after treatments of Riboflavin and (c) UV-cross-linking (c). The vertical axis represents 
axial depth (with the anterior corneal surface down) and the horizontal axis represents time. 
Figure 4  (and  Media 1) shows B-scan measurements of the same cornea. As seen in 
Media 1, several images are captured during the corneal deformation event. The two extreme 
deformation conditions shown in Fig. 4 were used to extract the quantitative deformation 
parameters: the image of the stable non-deformed cornea (reference condition), shown in red; 
and the image of the maximum transient deformed cornea, overlapped in green. 
 
Fig. 4. Single-frame excerpts from an example video recording (Media 1) of the dynamics of 
horizontal sections of the cornea (B-scans), for three different conditions of the same in vitro 
porcine eye: (a) virgin eye with no treatment; (b) after instillation of Riboflavin; and (c) after 
UV-cross-linking. The stable non-deformed cornea (reference condition) is shown in red, and 
the deformed cornea is overlapped in green. 
Figures 3 and 4 show the capability of the proposed methodology to retrieve information 
of the dynamic response of the cornea, with sufficient temporal (A-scans) and spatial (B-
scans) resolution to extract quantitative parameters that describe the corneal deformation as a 
result of a 20-ms air-puff. The air-puff (conventionally used in tonometry) produces a very 
relevant corneal deformation in all conditions, although differences in the temporal and spatial 
shape of the corneal deformation occur across conditions. 
3.2. Deformation amplitude and corneal thickness 
Figure 5a  shows the deformation amplitude and the corneal thickness for the different 
conditions: human eye in vivo (in green), and porcine corneas (untreated in deep blue, after 
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deformation amplitude in the living human cornea was 0.56 ± 0.04 mm. Untreated porcine 
eyes experienced a larger deformation (0.85 ± 0.26 mm on average). The porcine corneas 
instilled with Riboflavin showed a mean deformation amplitude similar to that of virgin 
porcine eyes, although with less variability across eyes (0.87 ± 0.09 mm). After UV-cross-
linking (CXL), the deformation amplitude was 0.61 ± 0.01 mm, significantly lower (p<0.02) 
than in untreated porcine eyes. 
These deformation amplitudes are affected by corneal thickness. The measured human 
corneal thickness was 0.76 ± 0.01 mm, higher than the corresponding deformation amplitude. 
In porcine corneas, the instillation of Riboflavin + Dextran produced a strong reduction in 
corneal thickness (from 1.19 ± 0.03 mm in virgin eyes to 0.62 ± 0.05 mm), consistent with the 
de-hydration effects produced by Dextran [23,41]. UV-cross-linking produced further 
decrease in corneal thickness (down to 0.56 ± 0.02 mm). 
Corneal thickness was measured before the deformation event (results described above), 
as well as at the moment of maximum deformation and immediately after the recovery. The 
difference in thickness (during and after the deformation, with respect to the thickness before 
the deformation, averaged across eyes in the same condition) was negative in all cases 
(Untreated, Riboflavin and UV-cross-linking). The thickness difference ranged between 
−0.007 and −0.07 mm, suggesting a slight reduction in corneal thickness during and after the 
applanation. However, this difference was only statistically significant (paired t-test) in two 
cases: human eye after the deformation (−0.074 ± 0.044 mm, p = 0.005); and untreated 
porcine cornea during the deformation (−0.023 ± 0.017, p = 0.02). 
The ratio of deformation amplitude/corneal thickness (Fig. 5b) was similar for the 
untreated corneas, but changed with treatments. The deformation amplitude was lower than 
corneal thickness in untreated corneas, whereas it was higher for corneas instilled with 
Riboflavin and of the same magnitude in UV-cross-linked corneas. 
 
Fig. 5. (a) Deformation depth and corneal thickness (measured before the deformation event) at 
the corneal apex, in millimeters, for the different conditions. (b) Deformation amplitude / 
corneal thickness ratio. Error bars for the human eye in vivo (green columns) indicate the 
standard deviation across measurements for the same eye. Error Bars for porcine eyes in vitro 
(blue columns) indicate the standard deviations across measurements on different eyes. 
3.3. Deformation time 
It is interesting to note that the pulse duration (obtained from calibration measurements with 
the same setup) was longer (~20 ms) than the duration of the overall corneal deformation 
event measured: 14.3 ± 0.8 ms for the human eye in vivo and 17.3 ± 1.2 ms for the untreated 
porcine eyes. 
The different treatments applied to the porcine eyes (Riboflavin and UV-cross-linking) did 
not significantly affect the overall deformation duration, as shown in Fig. 6, but changed the  
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Fig. 6. (a) Duration of the corneal deformation parameters (overall deformation, increasing 
deformation period and decreasing deformation period) measured at the corneal apex, for the 
different conditions. (b) Time ratio (increasing deformation period/decreasing deformation 
period). The red horizontal line indicates the values at which the increasing deformation period 
duration equals the decreasing deformation period duration (time-symmetrical deformation). 
temporal symmetry of the deformation. In untreated corneas (both human and porcine) the 
duration of the increasing deformation period was longer than the duration of the decreasing 
deformation period (corneal recovery), indicating that the peak deformation position was 
displaced toward the end of the overall deformation period (the effect being stronger for the 
human cornea). With treatments, the increasing deformation period (inward deformation) was 
reduced, while the decreasing deformation period (recovery time) obtained was longer. This 
effect is more clearly shown in Fig. 6b. The displacement of the peak symmetry toward the 
end of the ablation found in untreated corneas (increasing/decreasing time ratio > 1) was 
reduced with the treatments in porcine corneas. Deformation events after Riboflavin were 
almost temporally symmetrical. After UV-cross-linking, the temporal symmetry of the 
deformation was inverted, and the peak deformation displaced to the first half of the 
deformation period. 
3.4. Deformation speed 
Figure 7 shows parameters associated with the speed of the deformation at the corneal apex. 
The peak speed of the increasing deformation period (first period of the deformation event) 
was quite constant across conditions (see Fig. 7.a), around 0.12 mm/ms. However, the peak 
speed of the decreasing deformation period (peak deformation recovery speed) was different  
 
Fig. 7. (a) Deformation speed at the corneal apex, for the different conditions, obtained from 
measurements at the apex. (b) Peak-Speed ratio (increasing deformation period/decreasing 
deformation period). The red horizontal line indicates the values at which the peak deformation 
speed of the increasing deformation period equals the peak speed of the decreasing deformation 
period. 
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porcine corneas, and 0.12 for the UV-cross-linked corneas, indicating a much slower 
deformation recovery after UV-cross-linking. The trends were similar for mean speeds 
(instead of peak speeds), although with reduced differences across conditions and lower 
values. 
Figure 7b shows the ratio of the peak-deformation-speed in the increasing deformation 
period vs the decreasing deformation period (speed of recovery). In human corneas this ratio 
was close to unity. Both untreated and Riboflavin porcine corneas had ratios well below unity 
(0.66), indicating a peak deformation speed higher in the recovery than in the increasing 
(inward) deformation period. UV-cross-linked porcine corneas experienced an important 
increase in this ratio, which was found to be 0.999 ± 0.1, indicating an identical peak speed in 
both deformation periods. 
3.5. Effects of treatment in the same eye 
The previous comparisons between untreated and treated porcine eyes were based on the 
average values obtained for each condition. Figure 8 describes the longitudinal response of the 
same individual porcine eyes before and after the treatments. Data are represented in terms of 
ratios treated/untreated, with the treatment referring to Riboflavin + Dextran instillation and 
UV-cross-linking (left panel) or de-epitheliazation alone (right panel). The untreated reference 
condition corresponds to the measurements on the virgin eye. Figure 8 shows that all the 
parameters (except the overall duration of the deformation event) changed with the UV-cross-
linking treatment, and that these changes were larger than the standard deviation across eyes. 
The longitudinal results confirm the results of Figs. 5-7 on UV-cross-linking vs control 
group differences: (1) UV-cross-linking reduced the amplitude of corneal deformation; (2) 
Riboflavin + Dextran produced a decreased corneal thickness which was maintained after  
 
Fig. 8. Longitudinal changes induced in the parameters describing the dynamics of the corneal 
apex by different treatments on the same eyes. LEFT Panel: After de-epitheliazation and 
instillation of Riboflavin (RIBO, in neutral blue); and after additional UV-cross-linking (CXL, 
in light blue). Data of the left panel represent average and standard deviations of the evolution 
of different eyes. RIGHT Panel: After de-epitheliazation alone (De-EPI, in green). Data on the 
right panel represent average and standard deviation of repeated measurements of one eye. 
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Treatments induced changes in the temporal displacement of the peak deformation; (5) UV-
cross-linking decreased the deformation speed; (6) UV-cross-linking increased the speed ratio 
(increasing / decreasing deformation speed). In addition, the longitudinal analysis (Fig. 8) 
reveals additional findings for the Riboflavin condition, which were likely masked by 
individual variability of the eyes in the cross-sectional analysis: Riboflavin produced changes 
in temporal symmetry (like those already observed in UV-cross-linking condition in the cross-
sectional analysis) and reduced the deformation mean and peak speeds (except for the mean 
speed in the increasing deformation period). 
While the treatments with Riboflavin and, more importantly, UV-cross-linking are 
expected to change the biomechanical properties of the tissue, there are other structural 
changes likely changing the dynamic response of the cornea to the air puff event. The right 
panel of Fig. 8, representing the results for de-epitheliazation alone, is shown as a reference. 
De-epitheliazation reduces corneal thickness, therefore inducing some changes in the corneal 
response to the air puff, but it is not expected to affect the biomechanical properties of the 
tissue. Figure 8 (right panel) shows these measured changes. All the parameters, except those 
related to temporal durations and mean speeds, were statistically significant (unpaired t-tests, 
p<0.05). The deformation amplitude was slightly increased and therefore the 
deformation/amplitude ratio, and the deformation speeds were also increased, although mean 
speed changes were not significant. The increasing/decreasing speed ratio was also increased 
by de-epitheliazation alone. 
3.6. Imaging the deformation of the full cornea 
Figure 9 describes the deformation parameters (see Fig. 2b for a schematic diagram of the 
same) obtained from dynamic images of horizontal cross-sections of the cornea (as those 
shown in Fig. 4) in porcine eyes with different treatments. The deformation diameter (5.7 ± 
0.8 mm in the untreated corneas) was reduced with the treatments (5.1 ± 0.3 mm after 
Rivoflavin and 4.4 ± 0.1 after UV-cross-linking). The reduction in deformation diameter after 
UV-cross-linking was statistically significantly different (p<0. 02; two-sample t-test with 
unequal variances): 23% with respect to the untreated condition, and 14% with respect to the 
Riboflavin condition. 
 
Fig. 9. Deformation parameters from dynamic images of the spatial deformation of the cornea 
(B-scan measurements along the horizontal meridian), for porcine in vitro eyes with different 
treatments. (a) Deformation diameter, non-deformed corneal radius and peak deformed corneal 
radius (the curvature sign is inverted in all cases). (b) Displaced volume. Error bars indicate the 
standard deviations across measurements on different eyes. 
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change across treatments. However, the deformed corneal radius (measured at the moment of 
peak deformation) was reduced with Rivoflavin (from 5.7 to 4.9 mm), but it was later 
significantly increased (6.0 mm; p<0.02) by UV-cross-linking. The sign of the fitted radius 
was reversed in all the deformed corneas, indicating an inversion of the curvature of the 
cornea, as already shown in Fig. 4. 
Figure 9b shows the corneal volume displaced by the air puff, at the moment of maximum 
deformation. UV-cross-linking produced a large decrease of displaced volume, from 10.1 
mm
3 in untreated corneas and 7.7 mm
3 in corneas with Riboflavin, to 4.0 mm
3 (on average 
across eyes). The high variability found in untreated corneas (in accordance with the high 
variability observed in the deformation amplitude, see Fig. 5a) was reduced with Riboflavin + 
Dextran instillation. 
Although the cornea moves at  high speed during the deformation event (Fig. 7), the 
exposure time for each A-scan is only 15 us, preventing motion-blur. However, due to the 
sequential acquisition, some corneal points appear retarded with respect to others in the 
horizontal cross-sectional images. For peak corneal deformation speed the delay of some 
points with respect to other laterally displaced points (and therefore scanned at a different 
time) induces the observed slight asymmetries in the images of the full deformation (see 
Media 1), which are therefore likely to arise from scanning. However, the quantitative 
measurements provided in Fig. 9 refer to the time point of maximum deformation amplitude, 
in which the deformation speed is zero, for which this effect is not present. In fact, around the 
peak deformation time, the cornea appears stable (with several consecutive frames 
superimposed) and with maximum symmetry. 
4. Discussion 
We have demonstrated a new technique for the non-invasive imaging of the dynamic response 
of the cornea to an air puff inducing deformation, based on high-speed sOCT. The non-
collinear configuration has allowed both for the high-speed evaluation of the dynamics of the 
corneal apex [39], and the imaging of the spatial corneal deformation over corneal cross-
sections [30,31]. 
This new generation of imaging techniques in-vivo will potentially provide biomechanical 
information in individual eyes, avoiding the limitations of prior in-vivo techniques [23–25,42] 
(which provided only indirect information) and of in vitro techniques such as extensiometry 
[15] (which alter the anatomical integrity of the eye) or corneal button/whole eye inflation 
models [16,21] (which are subject to hydration and preservation issues). 
The sensitivity of the technique has proven to be higher  than existing techniques, as 
differences in corneal deformation dynamics across species and treatments are clearly 
detected. Furthermore, the entire deformation process can be dynamically visualized and 
studied quantitatively, allowing direct extraction of deformation parameters. 
For untreated porcine eyes, the different hydration states are the main source of variability 
across eyes. In treated porcine eyes, dehydration reduces this effect, and individual differences 
across eyes in tissue properties appear. In human eyes, the reduced signal to noise ratio 
introduces some uncertainty in the image analysis, but it is very low compared with the 
variability introduced by eye movements and positioning errors (not present in in vitro eyes). 
Despite the lower thickness of the human cornea as compared to the porcine corneas, the 
lower deformation amplitude (as well as shorter deformation durations and reduced 
deformation speeds) found in the study is indicative of a higher stiffness of human corneal 
tissue, in agreement with previous comparative reports of human and porcine corneal 
biomechanical properties [6,17]. However, this result could be affected by differences in the 
geometry and intraocular pressure across the tested eyes. 
In porcine corneas in vitro, where intraocular pressure was kept constant across eyes and 
treatments, we found a significantly different corneal response across conditions: virgin 
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cross-linking. The corneal response after the UV-cross-linking treatment (and, to a minor 
extent, after Riboflavin) is consistent with an increase in corneal stiffness, as it produces 
reduced deformation amplitudes, reduced displaced volumes, and reduced deformation speeds 
to the same air-puff stimulus. This result is consistent with other studies aiming at estimating 
biomechanical properties of the cornea, following different approaches and time scales [5,21]. 
This study also shows that Riboflavin and UV-cross-linking produce changes in the temporal 
symmetry of the deformation event (a displacement in the peak amplitude toward the start of 
the deformation). The corneal recovery period is longer, and is also slower, compared to 
virgin and de-epithelialized corneas. The increasing/decreasing speed ratio appears as a very 
sensitive parameter to differences in treatment: it is increased with de-epitheliazation, reduced 
to the virgin corneas values after Riboflavin instillation (although with slightly reduced 
absolute speeds), and strongly increased with UV-cross-linking (with the absolute speeds 
reduced much more), indicating that the speed reduction is more important in the recovery 
period. These temporal and speed changes between the periods of increasing deformation and 
recovery suggest marked changes in the viscoelasticity of the tissue. 
The different corneal responses (to the same deformation stimuli) obtained after treatments 
indicate that there are marked biomechanical changes induced on the cornea. These 
differences are revealed by geometrical changes at a macroscopic scale upon deformation, but 
are likely the result of changes in the microscopic structure of the cornea. The relative 
contribution of the corneal geometry (mainly changes in thickness, and to a lesser extent in 
curvature), intraocular pressure and material constituent properties to the effect remains an 
interesting question, where the experimental data can provide insights. 
De-epitheliazation alone (right panel of Fig. 8), which only produces a small reduction in 
corneal thickness (10%) and minimal changes in the stromal arrangement, produces some 
changes in speed deformation parameters (but not other parameters), indicating a minor 
contribution of the epithelium to corneal biomechanics. The fact that Riboflavin alone 
produces significant changes in corneal deformation (in comparison with virgin corneas) is 
highly consistent with recent reports both from inflation models [23] and non-linear 
microscopy observations of collagen packing in Riboflavin + Dextran treated corneas [41], 
indicating both geometrical and ultra-structural changes. The instillation of Riboflavin + 
Dextran, and the subsequent corneal dehydration, also results in a reduction of corneal 
thickness (by 48%, Fig. 5a and Fig. 8), which is maintained after UV-cross-linking. However, 
the deformation parameters are capable of discriminating significantly across treatments (Fig. 
8): the deformation amplitude and the deformation speeds are decreased with Riboflavin and 
UV-cross-linking (while they are increased with de-epitheliazation alone) and the temporal 
distribution is affected (while it was not with de-epitheliazation). The difference in behavior is 
more apparent if we consider that all the treated corneas (with Riboflavin, followed by UV-
cross-linking or not) have been previously de-epithelialized. The differences in the 
deformation patterns that change with corneal thickness, cannot explain the changes in the 
biomechanical response observed after Riboflavin and UV-cross-linking. Conversely, the 
small change observed in the amplitude of the corneal deformation after Riboflavin, which is 
very similar to that of virgin eyes (Fig. 5 and Fig. 8) despite the drastic decrease (almost 50%) 
in thickness, cannot be explained by a thickness change alone. The  strong reduction in 
deformation amplitude (26%) between UV-cross-linking and Riboflavin treated corneas (with 
similar thickness), reveals the changes induced by UV-cross-linking at the microscopic level, 
and the stiffening effect of the UV-cross-linking treatment. 
Our results also show that the deformation diameter and the displaced volume are reduced 
with the treatments, which also change the radius of the deformed cornea (Fig. 9). Corneal 
curvature (and differences across eyes and conditions) could play a role in corneal 
deformation. Although corneal steepening has been reported clinically during the first month 
following UV-cross-linking [43], and this was observed also 24-hours after treatment in an in 
#159961 - $15.00 USD Received 13 Dec 2011; revised 17 Jan 2012; accepted 17 Jan 2012; published 9 Feb 2012
(C) 2012 OSA 1 March 2012 / Vol. 3,  No. 3 / BIOMEDICAL OPTICS EXPRESS  486vitro model [21], differences in corneal radius of curvature were negligible immediately 
following treatment. This was further confirmed in our study, by imaging horizontal sections 
of the non-deformed corneas at constant pressure (Fig. 9). 
We have demonstrated a technique for the evaluation (in vivo and in vitro) of dynamic 
corneal deformation, capable of detecting differences across species and treatments. Temporal 
(Figs. 6, 7 and 8) and spatial (Fig. 9) measurements provide complementary (or even 
coincident—Fig. 5) descriptions of the deformation event. In particular, using this technique, 
we have confirmed non-invasively that UV-cross-linking induces changes in the corneal 
biomechanical properties, as recently reported using invasive techniques [21,41]. The 
differences must be the result of changes in constituent properties of the cornea, and not solely 
the results in changes in corneal thickness, geometry or IOP, as these were constant across 
some of the conditions. 
The retrieved deformation parameters (amplitude, radius, diameter and volume of the 
deformation, as well as duration and speeds of the deformation periods), in combination with 
measurements of corneal biometry and IOP, pulse calibration, will be extremely valuable 
experimental data in corneal biomechanical models. Although these findings are of interest in 
the understanding of tonometric measurements of the cornea, the ultimate goal is to obtain the 
biomechanical properties of the tissue based on image-based measurements of corneal 
deformation. This information will serve as experimental inputs in finite element models of 
the normal, pathological and treated cornea [23], at an individual level, to improve diagnosis 
and prognosis of the disease and treatment. The developed technology can also help to 
understand the sources of the variation in the  deformation response across corneas and 
conditions, including biomechanical properties of the tissue (elasticity and viscoelasticity), the 
changes in the structural properties of the corneas (as geometry) or the effect of IOP pressure 
(which was kept constant in our experiment). 
5. Conclusions 
The combination of high-speed sOCT imaging with air puff deformation shows a great 
potential as a research and clinical tool to retrieve the biomechanical properties of individual 
corneas, in vivo. 
The non-collinear configuration presented in this study, makes available both, images of 
the corneal deformation over full corneal cross-sections, and also high speed measurements of 
the temporal evolution of the corneal apex. 
The quantitative description provided by the set of deformation parameters proposed has 
proven to be sufficiently sensitive to detect, not only differences across species and 
treatments, but also across individual eyes. The differences found must be the result of 
changes in constituent properties of the cornea, and not a consequence of changes in corneal 
thickness, geometry or IOP. 
These measurements could serve as potential inputs to be used in finite element models of 
the normal, pathological and treated cornea, and are a first step for the estimation of the 
biomechanical properties of corneal tissue, at an individual level and in vivo, to improve 
diagnosis and prognosis of diseases and treatments. 
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